Canadian Cancer Trials Group receives $8.7 million from the Canada Foundation for Innovation

12 January 2017

Toronto -

Earlier this week the Canadian Cancer Trials Group (CCTG) received a five year, $8.68 million grant from the Canada Foundation for Innovation under the Major Science Initiatives Fund. This funding will support CCTG’s Operations and Statistics Centre at Queen’s University in Kingston.

“We are honoured that the quality and scope of the work undertaken by CCTG has been recognized by the Canada Foundation for Innovation,” says Dr. Janet Dancey, Director of CCTG. “This significant grant will help us continue our ground-breaking national and international research, leading to better treatments and improved outcomes for people with cancer.”

CCTG is a cancer research cooperative that provides the expertise and infrastructure for researchers to conduct national and international phase I-III cancer clinical trials. As one of the national programs of the Canadian Cancer Society, CCTG has supported over 500 trials in over 40 countries aimed at improving survival rates and quality of life for cancer patients around the world.

The Major Science Initiatives (MSI) fund supports ongoing operations and maintenance costs for a select group of national research facilities – facilities which address the needs of a key community of Canadian researchers and which contribute to Canada’s reputation as a global leader in research and innovation.

“Through the MSI program, the Government of Canada clearly recognizes the importance of sustaining key research platforms and supporting large-scale collaborations that are conducting leading-edge research with global impact,” says Steven Liss, Queen’s University-Vice-Principal (Research).

On Monday, the Honourable Kirsty Duncan, Minister of Science, announced an investment of a total of $328.5 million to ensure the optimal performance of 17 national research facilities led by 12 universities across the country.

About the Canada Foundation for Innovation
Created in 1997, the Canada Foundation for Innovation makes financial contributions to Canada’s universities, colleges, research hospitals and non-profit research organizations to increase their capability to carry out high quality research. The foundation awards funding through a rigorous competitive and independent merit-review process. Funding is awarded based on the quality of the research proposed and its need for infrastructure, its contribution to strengthening the capacity for innovation and the potential benefits of the research to Canada.

For more information on the Canada Foundation for Innovation, or the Major Science Initiatives Fund, please visit their website.

About the Canadian Cancer Trials Group
The Canadian Cancer Trials Group (CCTG) is a cancer clinical trials research cooperative that runs phase I-III trials to test anti-cancer and supportive therapies in 80 institutions across Canada and internationally. CCTG is one of the national programs of the Canadian Cancer Society Research Institute (CCSRI), and is supported by the Canadian Cancer Society (CCS). From its centre at Queen’s University in Kingston, Ontario, CCTG has supported over 500 trials in over 40 countries, aimed at improving survival rates and quality of life for cancer patients.

About the Canadian Cancer Society
The Canadian Cancer Society funds the best cancer research in Canada thanks to our generous donors and our rigorous peer-review process. We are the largest national charitable funder of cancer research in Canada, funding hundreds of researchers in universities, hospitals and research centres. For more information, visit cancer.ca or call our toll-free bilingual Cancer Information Service at 1-888-939-3333 (TTY 1-866-786-3934).

The Canadian Cancer Society is a national community-based organization of volunteers whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer. When you want to know more about cancer, visit our website www.cancer.ca or call our toll-free, bilingual Cancer Information Service at 1 888 939-3333.

For more information, please contact:

Rosie Hales

Communications Specialist

Canadian Cancer Society

National office

Phone: 416 934-5338